Pre-Conference Day

Reducing vein-to-vaccine timelines and achieving sustainable cost of goods requires more than operational optimization alone. This workshop will explore where speed and cost are truly won or lost across development, manufacturing, testing, and supply chain strategy, and what it takes to build commercially scalable personalized cancer vaccine programs.

Join this workshop to:

• Identify which platform-level design choices (formulation complexity, cold-chain dependency, antigen design/selection speed) set the real ceiling on vein-to-vaccine timelines, independent of downstream process optimization
• Explore how advances in antigen design and selection are compressing design-to batch-release timelines across different technology approaches
• Optimize analytical and assay strategies to enable rapid batch release while maintaining product quality, safety, and regulatory compliance
• Benchmark COGS drivers across personalized cancer vaccine technologies to identify where sustainable commercial economics are actually won or lost

Establishing clinical trials for personalized cancer vaccines requires aligning regulatory strategy, patient selection, manufacturing logistics, and clinical operations within tight timelines. This workshop will explore practical approaches to trial design, manufacturing integration, immune monitoring, and regulatory planning, sharing key lessons learned to streamline execution and improve clinical development success.

Join this workshop to:

• Navigate regulatory pathways to accelerate approval timelines and reduce compliance risks
• Optimize patient selection strategies to improve enrollment rates and enhance trial outcomes
• Manage costs and resources to maximize budget efficiency and ensure trial sustainability
• Select clinical sites strategically to enhance patient recruitment and data quality
• Learn from trial outcomes to apply proven insights and avoid common pitfalls